Twist Bioscience Corp (TWST, Financial) is set to release its Q2 2025 earnings on May 5, 2025. The consensus estimate for Q2 2025 revenue is $91.99 million, and the earnings are expected to come in at -$0.58 per share. The full year 2025's revenue is expected to be $376.01 million and the earnings are expected to be -$2.21 per share. More detailed estimate data can be found on the Forecast page.
Twist Bioscience Corp (TWST, Financial) Estimates Trends
Revenue estimates for Twist Bioscience Corp (TWST) have increased from $373.10 million to $376.01 million for the full year 2025 and from $438.84 million to $442.83 million for 2026 over the past 90 days. Earnings estimates have improved from -$2.37 per share to -$2.21 per share for the full year 2025, while they have remained flat at -$1.75 per share for 2026 over the past 90 days.
Twist Bioscience Corp (TWST, Financial) Reported History
In the previous quarter ending December 31, 2024, Twist Bioscience Corp's (TWST) actual revenue was $88.71 million, which beat analysts' revenue expectations of $86.97 million by 2%. Twist Bioscience Corp's (TWST) actual earnings were -$0.53 per share, which beat analysts' earnings expectations of -$0.64 per share by 16.8%. After releasing the results, Twist Bioscience Corp (TWST) was up by 0.73% in one day.
Twist Bioscience Corp (TWST, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 11 analysts, the average target price for Twist Bioscience Corp (TWST) is $53.74 with a high estimate of $65.00 and a low estimate of $45.00. The average target implies an upside of 42.52% from the current price of $37.71.
Based on GuruFocus estimates, the estimated GF Value for Twist Bioscience Corp (TWST, Financial) in one year is $59.61, suggesting an upside of 58.07% from the current price of $37.71.
Based on the consensus recommendation from 13 brokerage firms, Twist Bioscience Corp's (TWST, Financial) average brokerage recommendation is currently 2.0, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies strong buy, and 5 denotes sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
